Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital

Emergency Medicine Journal

Volumn 30, Issue 1, 2013, Pages 63-67

  Roulet, Lucien ^a,b   Ballereau, Françoise ^a,b   Hardouin, Jean Benoît ^a,c   Chiffoleau, Anne ^a   Moret, Leïla ^c   Potel, Gilles ^a,b   Asseray, Nathalie ^a,b  

^a Teaching Hospital   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Universite de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIORITY JOURNAL; TEACHING HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; DRUG TOXICITY; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEMALE; FRANCE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84872362789     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2011-200482     Document Type: Article

References (26)

1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274:29-34.
2. Budnitz DS, Pollock DA, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296:1858-66. (Pubitemid 44596195)
3. Queneau P, Trombert B, Carpentier F, et al APNET. [Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures] (In French). Ann Pharm Fr 2005;63:131-42.
4. Queneau P, Bannwarth B, Carpentier F, et al APNET. Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf 2007;30:81-8. (Pubitemid 46072360)
5. Trifirò G, Calogero G, Ippolito FM, et al. Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf 2005;14:333-40.
6. Wasserfallen J, Livio F, Buclin T, et al. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001;12:442-7. (Pubitemid 32823524)
7. Corral Baena S, Guerrero Aznar MD, Beltran Garcia M, et al. Use of MBDS as a tool for the detection of drug-related adverse events. Farm Hosp 2004;28:258-65. (Pubitemid 39273008)
8. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004;50:631-6. (Pubitemid 39388975)
9. Sánchez Cuervo M, Delgado Téllez de Cepeda L, Delgado Silveira E, et al. [Detection and analysis of adverse drug reactions in a general hospital's emergency department] (In Spanish). Farm Hosp 2006;30:78-84.
10. Zanocchi M, Tibaldi V, Amati D, et al. Adverse drug reactions as cause of visit to the emergency department: incidence, features and outcomes. Recenti Prog Med 2006;97:381-8. (Pubitemid 44125335)
11. Hafner JW Jr, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39:258-67. (Pubitemid 34219639)
12. Yee JL, Hasson NK, Schreiber DH. Drug-related emergency department visits in an elderly veteran population. Ann Pharmacother 2005;39:1990-5. (Pubitemid 41745941)
13. Tippinq B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients: a prospective cross-sectional study. S Afr Med J 2006;96:1255-9. (Pubitemid 46070629)
14. Patel KJ, Kedia MS, Bajpai D, et al. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007;7:8.
15. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-9. (Pubitemid 351860342)
16. Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005;43:1171-6. (Pubitemid 43012173)
17. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801. (Pubitemid 38623529)
18. Hohl CM, Robitaille C, Lord V, et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med 2005;12:197-205. (Pubitemid 40248878)
19. Hohl CM, Zed PJ, Brubacher JR, et al. Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med 2010;55:493-502.
20. WHO. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser 1972;498:1-25.
21. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81. (Pubitemid 36962641)
22. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
23. Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991;39:1093-9.
24. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005;22:767-77.
25. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-66.
26. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. (Pubitemid 36437933)